During normal pregnancy, the thymus undergoes a severe reduction in size and thymocyte output, which may contribute to maternal-fetal tolerance. It is presently unknown whether the pregnancy-induced thymic involution also affects nonlymphoid thymic cell populations and whether these changes in stromal cells play a role in the reduction in thymocyte numbers. Here, we characterize the changes in thymic lymphoid and nonlymphoid cells and show that pregnancy results in a reduction of all major thymic lymphoid cell populations, including the early T-lymphoid progenitors (TLPs) and thymic regulatory T cells. In addition to the thymocytes, the thymic involution also includes all major nonlymphoid cell populations, which show a profound reduction in cell numbers. We also show that during pregnancy, the thymic nonlymphoid cells exhibit decreased expression of chemokines that are essential for TLP homing: CCL25, CXCL12, CCL21, and CCL19. In addition, the expression of these chemokines was substantially downregulated by shortterm treatment with progesterone but not estrogen. Collectively, these findings suggest a novel mechanism for the pregnancy-induced reduction in TLP homing and the resulting thymic involution.
Introduction
The developing fetus expresses paternal antigens and, therefore, should be rejected by the maternal immune system [1] [2] [3] . However, during normal pregnancy, the accompanying changes in the maternal immune system allow the semiallogenic fetus to be tolerated. Accordingly, insufficient immune modulation and a failure of tolerance induction to the developing fetus have been linked to involution have been focused on pregnancy-related increases in certain steroid hormones and their effects on different thymocyte populations. For example, it has been shown that progesterone signaling is needed for thymic involution in pregnancy and this effect is related to a developmental block of thymocyte differentiation at the double negative (DN)1 stage [10] . Another study indicated that the pregnancy-induced increase in the estrogen level is responsible for diminished proliferation of virtually all thymocyte populations without affecting their apoptosis [10, 11] . However, there is currently no data available regarding whether the pregnancy-induced changes in cell proliferation affect only the thymic cells of lymphoid origin or also expand to cells other than the thymocytes.
In addition to different thymocyte subsets, the thymus comprises a diverse set of functionally distinct nonlymphoid cells that all contribute to the stepwise differentiation of thymocytes [12] [13] [14] . While the interactions between cortical thymic epithelial cells (cTECs) and thymocytes are responsible for TCR-mediated positive selection, the medullary thymic epithelial cells (mTECs) and dendritic cells (DCs) express and present self-antigens and co-stimulatory molecules to the developing thymocytes and play a central role in negative selection and the induction of central tolerance. In addition, it has been shown that TECs and fibroblasts produce many soluble factors and transmembrane proteins such as IL-7, Kitl, and Dll4 that are essential for thymocyte proliferation, differentiation, and survival [15] [16] [17] [18] whereas thymocyteproduced factors such as RANKL, CD40, and LTβ are critical for the proper differentiation of TECs [19] [20] [21] [22] [23] . Thus, it is well established that bidirectional crosstalk is required for the proper function of both lymphoid as well as nonlymphoid thymic cells. Whether pregnancy or pregnancy-related hormones have any effect on the different subpopulations of thymic nonlymphoid cells and whether these changes contribute to the pregnancy-related thymic involution is currently not known.
The foremost prerequisite for T-cell development is the thymic seeding by T-lymphoid progenitors (TLPs) that are attracted to the thymus by chemotactic signals released by thymic nonlymphoid cells [24] . The seeding of TLPs has been shown to depend on their coordinated surface expression of CCR7, CCR9, and CXCR4 and, accordingly, the corresponding KO models present with severe defects in thymocyte homing [25] [26] [27] [28] [29] [30] . It has also been shown that in the thymus, the ligands for these chemokine receptors can be produced by a variety of nonlymphoid cells [27-29, 31, 32] . However, to date, there have been no quantitative data comparing the contribution of different nonlymphoid subsets to the production of specific chemokines essential for TLP homing. It is also unknown whether the production of these chemokines is affected by normal pregnancy or pregnancy-related hormones.
This study aimed to characterize the pregnancy-induced changes in different populations of mTECs, cTECs, thymic fibroblasts, and DCs, together with the changes in different thymocyte populations. We also aimed to define the thymic cellular source for the ligands of CCR7, CCR9, and CXCR4 and to determine whether normal pregnancy or pregnancy-related hormones modulate the expression of the chemokines required for TLP homing.
Results

Pregnancy results in a progressive loss of thymocytes and thymic nonlymphoid cells
It has been well established that pregnancy results in a progressive thymic involution characterized by profound reduction in thymocyte numbers [8] [9] [10] [11] . Here we aimed to determine the pregnancyinduced changes that affect the nonlymphoid cells in the thymus over the time course of the involution. First, we measured the body weight and thymic weight at a time point in each of the three trimesters of pregnancy and established that the involution exhibits a negative correlation with the body weight and starts during the second trimester while reaching its peak by the end of pregnancy ( Fig. 1A ). In agreement with the smaller thymus weight, the numbers of thymic CD45 + cells, mostly representing thymocytes, were reduced by the second trimester and were dramatically decreased by late pregnancy. At the same time, the thymic involution also involved the thymic nonlymphoid compartment, with a fivefold decrease in thymic CD45 − cells observed at late pregnancy ( Fig. 1B ). However, even at late pregnancy, the robust histological structure of the thymus, including the rough proportions of cortical and medullary areas, was unchanged compared to nonpregnant age-matched mice (Fig. 1C ). Likewise, there was no major change in the expression pattern of the key inducer of central tolerance, Aire [33] , or in the expression pattern of involucrin, a marker of post-Aire mTECs and Hassall's corpuscles [34] .
Pregnancy-induced reduction in thymocyte numbers involves TLPs and Treg cells
Previous data on the subpopulations of thymocytes affected during pregnancy have indicated that there is a block in thymocyte development at the DN1-DN2 stage that leads to a proportional increase in the DN1 population and a proportional decrease in the DN2 population, whereas there were no major changes in other thymocyte subsets [10] . Another study that looked at the total numbers of different thymocyte subsets suggested that pregnancy results in a universal drop in all classic thymocyte populations [11] . In the present study, we quantified both the total numbers as well as the relative numbers of thymocytes and found that there were no major changes in the proportions of DN, DP, and SP cell populations ( Fig. 2A ). However, within the DN cells, the DN1 population showed a progressive increase during pregnancy ( Fig. 2A ) and by the third trimester the percentage of DN1 cells was significantly increased as compared with the nonpregnant controls (Student's t-test: p < 0.05, n = 6). At the same time, the total numbers of all thymocyte populations showed a progressive decrease during pregnancy ( Fig. 2B ), including the DN1 population that was significantly reduced by the third trimester as compared with the nonpregnant controls (Student's t-test: p < 0.05, n = 6). Thus, our data are compatible to the previous study reporting a developmental block at DN1-DN2 stage but also suggests that there is a decrease in TLP seeding as the total numbers of DN1 thymocytes clearly diminish, despite their concurrent accumulation.
Since the accumulation of Treg cells at the maternal-fetal interface has been suggested as one of the major mechanisms underlying pregnancy-induced immune tolerance [35, 36] , we specifically evaluated the numbers of thymic Treg cells during the progression of pregnancy. We found that although the proportion of Foxp3 + thymic Treg cells showed a slight but statistically significant increase by the third trimester of pregnancy (Student's t-test: p < 0.05, n = 6), the total numbers of thymic Treg cells showed a clear and continuous decrease as pregnancy advanced ( Fig. 2C) and were significantly diminished by the third trimester as compared with nonpregnant controls (Student's t-test: p < 0.05, n = 6). However, even at late pregnancy, the distribution of thymic Foxp3 + cells resembled that of control thymi and the cells were predominantly localized in medullary areas ( Fig. 2D ).
Pregnancy induces a reduction in thymic nonlymphoid cell numbers and downregulation of E2F3
In order to determine which thymic nonlymphoid cell populations are affected by normal pregnancy, we quantified the absolute and relative numbers of five major thymic cell populations: the class II high mTECs (mTEC high ), class II low mTECs (mTEC low ), cTECs, fibroblasts, and DCs by FACS at the three time points during pregnancy. As indicated by the total numbers, all five cell populations showed a progressive decrease in numbers that started during the second trimester and reached a peak at the third trimester of preg-nancy ( Fig. 3A and B) suggesting that, in addition to the effects on thymocyte populations, all major nonlymphoid cell populations were significantly affected. However, as indicated by the percentages of different cell populations, the proportions of nonlymphoid cells clearly changed by the end of pregnancy. On top of the major drop of all CD45 − cells, the mTEC high population showed a further decrease in relative numbers, while the percentages of cTECs and fibroblasts increased during the third trimester. Nevertheless, the proportions of mTEC low and DC populations remained stable throughout the course of pregnancy.
It has previously been shown that thymic involution in aging is associated with a downregulation of the activity of a transcription factor that plays a crucial role in cell cycle control, E2F3, in mTEC low and cTECs [37] . Thus, we analyzed whether similar changes also occur during pregnancy-induced thymic involution. Strikingly, the E2F3 levels were downregulated in the same highly proliferative cell populations ( Fig. 3C ), suggesting that the pregnancy-induced decrease in nonlymphoid cells shares a common mechanism with the involution induced by aging, and highlighting a central role for E2F3 in the control of thymic epithelial cellularity. However, pregnancy-induced involution was not associated with an upregulation of inflammatory cytokines, another central finding in age-induced thymic involution [37] , as demonstrated by a slight decrease in IL-1β and IL-6 in DCs and fibroblasts, respectively (Fig. 3C) .
In order to define whether pregnancy-induced involution may result from a decreased production of stromal cell-derived factors required for the functional thymocyte progenitor niche, we examined the expression levels of IL-7, Kitl, and Dll4 [15] [16] [17] [18] in different nonlymphoid cell subsets. Clearly, all three mediators showed a substantial decrease at late pregnancy (Fig. 3C) suggesting a potential role for the stromal cell-provided microenvironment in the pregnancy-induced block in thymocyte development and proliferation.
Pregnancy induces a decrease in the expression of ligands for CCR9, CXCR4, and CCR7
Because our data on the thymocyte subsets suggested that there was a diminished seeding of TLPs, we hypothesized that pregnancy induces substantial changes in the expression of the key chemokines required for TLP homing. Although several nonlymphoid cell types have been shown to produce ligands for CCR7, CCR9, and CXCR4 [27-29, 31, 32] , the relative contributions of different cell types in specific chemokine production have not been characterized. Thus, we first purified the five major thymic nonlymphoid cell populations from nonpregnant mice (mTEC high , mTEC low , cTEC, fibroblasts, and DCs), and determined the expression levels of ligands for CCR9 (CCL25), CXCR4 (CXCL12), and CCR7 (CCL21 and CCL19) by qPCR. Interestingly, among the thymic nonlymphoid cells, each of the measured chemokines had a clearly distinct prevailing cellular source ( Fig. 4 , transparent columns). Thus, in nonpregnant mice, CCL25 was predominantly produced by cTECs, CXCL12 by fibroblasts and cTECs, CCL21 by mTEC low , and CCL19 by mTEC high , whereas DCs produced only trace amounts of the chemokines measured. In order to determine if pregnancy induces changes in the chemokines required for TLP homing, we next measured the expression levels of these chemokines in purified nonlymphoid cells at the time points in the first, second, and third trimesters (Fig. 4, gray and black columns) . We observed a clear reduction of the production of all chemokines by their respective predominant cellular source (i.e. CCL25 from cTECs, CXCL12 from fibroblasts, CCL21 from mTEC low , and CCL19 from mTEC high ). Collectively, these data show that pregnancy induces a widespread downregulation in the expression of ligands for CCR9, CXCR4, and CCR7 and suggests a novel mechanism for the pregnancy-induced reduction in TLP homing and the resulting thymic involution.
Progesterone treatment mimics the pregnancy-induced changes in chemokine expression
Because previous reports have indicated a role for either estrogen or progesterone in pregnancy-induced thymic involution [10, 11] , we aimed to verify whether the changes in chemokine expression are mediated by one or the other of these pregnancy-related hormones. Thus, we treated nonpregnant mice with either estrogen or progesterone for 2 days and quantified the expression levels of the key chemokines in different nonlymphoid cell populations (Fig. 5 ). We established that estrogen treatment had no major effect on the expression of CCL25, CCL21, or CCL19 by their respective cellular sources, whereas the expression levels of CXCL12 by the cTECs were in fact increased after the estrogen treatment. To the contrary, short-term treatment with progesterone resulted in a significant decrease in CCL25 and CXCL12 expression in cTECs and CCL21 expression in mTEC low suggesting that the pregnancy-induced suppression in chemokine expression is at least partly mediated by progesterone.
Discussion
The development of T cells in the thymus is a stepwise progression through different epithelial-mesenchymal niches that depends on bidirectional communication between thymic stromal cells and thymocytes [12, 13] . It is well known that the differentiation of thymic epithelial cells is governed by different ligands of TNFR family members, RANKL, LTβ, and CD40L and, accordingly, the KO models of the respective receptors or signaling pathways show severe defects in TEC development, as well as a failure in central tolerance [19] [20] [21] [22] 38] . Likewise, the signals from thymic stromal cells are required for the thymocyte progenitor seeding, proliferation, migration, and differentiation [15] [16] [17] [18] 24] . Here we showed that pregnancy-induced thymic involution is accompanied by a profound reduction in all major nonlymphoid cell subsets, which is at least partly a result of decreased cell proliferation. In addition, on top of the reduced numbers of nonlymphoid cells, the stromal compartment downregulates the expression of the central mediators required for thymocyte differentiation and proliferation (IL-7, Kitl, and Dll4). Thus, the data indicate a central role for thymic nonlymphoid cells in pregnancy-induced involution that affects all of the major steps in thymocyte proliferation and development.
It has been well-established that the initial recruitment of the TLPs in the developing embryonic thymus depends on the expression of CCR9, CXCR4, and CCR7 on thymocyte precursors and the expression of the respective chemokines by thymic stromal cells [25] [26] [27] [28] [29] [30] . It is also known that the TLPs enter the thymus at the cortico-medullary junction and are first recruited toward the cortex, followed by migration to the medulla at their DP stage [24] . We herein showed that in the normal mature thymus, the predominant chemokines expressed by the cTECs and fibroblasts comprise the ligands for CCR9 (CCL25) and CXCR4 (CXCL12), whereas the ligands for CCR7 (CCL19 and CCL21) are mainly produced by the mTECs. Thus, the data indicate that in the mature thymus, CCR9 and CXCR4 likely mediate the initial recruitment of TLPs to the cortex, whereas CCR7 is likely involved in thymocyte migration at the later stages of development, i.e. during their migration from the cortex to the medulla. Additionally, we showed that during pregnancy, the levels of all of these chemokines are downregulated in their respective predominant cellular source and that shortterm progesterone treatment results in a similar downregulation of CCL25 and CXCL12 in the nonlymphoid cells. Collectively, these findings suggest a role for progesterone-mediated decrease in the production of CCL25 and CXCL12 in cTECs and fibroblasts as a mechanism for pregnancy-induced reduction in TLP seeding and subsequent thymic involution.
This study used three time points to determine the kinetics of pregnancy-induced changes in the thymus, and showed that although the major changes in all thymocyte subpopulations, including the TLPs, reach their peak by the end of pregnancy, most of the changes in chemokine expression are already present in the first trimester. However, as the number of thymic stromal cells (i.e. the cellular source of chemokines) is progressively decreasing, the net production of the key chemokines is likely to substantially decrease further as pregnancy advances, resulting altogether in a significant reduction of TLP homing by the third trimester.
A central role in the pregnancy-induced changes in the peripheral immune system is attributed to the augmented numbers and function of the Foxp3 + Treg cells [35, 36] . During normal pregnancy, Treg cells accumulate at the decidua, but are also increased in numbers in the peripheral blood. Here we showed that in the thymus, the percentages of Foxp3 + cells remained relatively stable throughout pregnancy and only showed a slight increase in the third trimester, which is in agreement with a previous report that used CD25 to distinguish the thymic Treg-cell subset [11] . More importantly, however, we showed that the total numbers of thymic Foxp3 + Treg cells decreased about fivefold by the third trimester. Thus, the data clearly suggest that there is no major pregnancy-induced increase in thymic Treg numbers indicating that the increased numbers and function of Treg cells seen in the periphery is a result of the peripheral proliferation of Foxp3 + cells.
In conclusion, the present study showed that pregnancyinduced thymic involution involves all major thymocyte populations, including the early TLPs. In addition to the thymocytes, thymic involution affects all major nonlymphoid cell populations that show a profound reduction in cell numbers. This study also shows that during pregnancy the decreased stromal cell populations downregulate their production of all major thymic chemokines that are essential for TLP homing and suggests a role for progesterone behind this effect. Collectively, the present data suggest a novel mechanism for the pregnancy-induced reduction in TLP homing and the resulting thymic involution.
Materials and methods
Mice C57BL/6 mice were maintained and experiments were performed at the Vivarium of the Institute of Biomedicine and Translational Medicine, University of Tartu. Pregnancy was determined by the presence of a vaginal plug and thymi were collected at three time points during the pregnancy: during the first (3-5 days), second (10-12 days), and third (17-19 days) trimesters. Age-matched female mice were used as controls. The weights of the mice and thymi were determined at the indicated time points using an analytical laboratory scale (Sartorius). All animal experiments were approved by the ethical committee of animal experiments at the Ministry of Agriculture, Estonia.
Cell sorting and analysis
The antibodies used in the study are listed in the Supporting Information Table 1 . Thymic cell populations were purified as previously described [39] . In short, individual thymi from pregnant mice or from matched nonpregnant controls were minced and gravity-sedimented several times in RPMI-1640 medium containing 2% FBS and 20 mM HEPES. The supernatants were pooled from individual thymi following each sedimentation step and used for the thymocyte population analysis. The enriched stromal compartment from each group was pooled and enzymatically digested in RPMI-1640 containing collagenase 2 (125 U/mL; Gibco) and DNase1 (15 U/mL; AppliChem) for 20 min at room temperature followed by two 20-min digestions containing also Dispase I (1 U/mL; Gibco). Following FcR blocking in 2.4G2 hybridoma medium (a kind gift from Dr. J. Dooley), the thymocytes and stromal cells were counted and stained for FACS sorting or analyses. The enriched stromal compartment was sorted into TRIzol LS Reagent (Life Technologies) with FACSAria (BD Biosciences) using the sorting strategy shown in Supporting Information Figure  1 . Thymocytes were analyzed using an LSRFortessa flow cytometer and the FACSDiva software (BD Biosciences).
RNA purification and qPCR
Cells were homogenized in the TRIzol reagent (Life Technologies), and RNA purification was carried out using RNeasy Micro Kits (Qiagen) according to the manufacturers' protocols, followed by reverse transcription using SuperScript III Reverse Transcriptase (Life Technologies). All qPCRs were carried out on a ViiA TM 7 Real-Time PCR System (Applied Biosystems). Every sample was run in three parallel reactions. Relative gene expression levels were calculated using the comparative Ct ( Ct) method (according to Applied Biosystems), where the relative expression was calculated as 2 − Ct , and where Ct represents the threshold cycle. β2-microglobulin was used as a house-keeping gene for normalization. The primers used are listed in Supporting Information Table  2 .
Immunofluorescence
Immunofluorescence staining was performed on frozen sections fixed with acetone. A 30-min blocking step at RT with 1% normal goat serum was used. Sections were incubated overnight with the indicated primary antibodies at 4°C, washed in PBS, and incubated with a corresponding secondary antibody (1:1000) for 60 min at room temperature. The slides were washed four times with PBS, then nuclei were stained with DAPI (1 μg/mL) for 10 min, the slides washed once more in PBS and covered with fluorescent mounting medium (Dako) and coverslips. Images were obtained with an LSM710 microscope (Zeiss).
Estrogen and progesterone treatments
Twelve-to 14-week-old female C57BL/6 mice were treated with vehicle, estrogen (intraperitoneal injections of 5 microg/mouse 17β-estradiol (Sigma, dissolved in saline)), or progesterone (subcutaneous injections of 1 mg/mouse progesterone (FARMAK, 2.5% oil solution)) on 2 consecutive days. Twenty-four hours after the last injection, the mice were sacrificed, thymi were removed, and thymic cell populations were purified and analyzed as described above.
